Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ID4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LTBP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TLX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ESPL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
H2AFY - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDKN2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UBR7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAXIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADCK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SIPA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRP72 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ENDOD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RANBP9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NUP50 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLUD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PID1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DPYSL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TEAD4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NFATC2IP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAPRIN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on